CompletedNot Applicable

WB-DW-MRI vs CHOLINE-PET/CT for Selecting Treatments in Recurrent Prostate Cancer

46 participantsStarted 2014-10

Plain-language summary

The purpose of this study is to determine the effectiveness of whole-body diffusion-weighted magnetic resonance imaging (WB-DW- MRI) in detecting metastases by comparing the results with those from choline-positron emission tomography-computed tomography (choline-PET/CT) in patients with metastatic/oligometastatic prostate cancer. Patients with this disease profile who could benefit from treatment with stereotactic body radiation therapy (SBRT) were selected and their responses to these techniques were rated.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Prostate cancer histologic diagnostic after one treatment * 5 o less lessions * Asimptomatic lessions * Informed Consent Form signed Exclusion Criteria: * Not capability to perform NMR os CT/PET scans

What they're measuring

effectiveness of whole-body diffusion-weighted magnetic resonance imaging (WB-DW- MRI) in detecting metastases

Timeframe: 2 years

Trial details

NCT IDNCT02858128

SponsorHospital Provincial de Castellon

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2015-03

View on ClinicalTrials.gov More Prostate Cancer trials